Highlights from the 13th African Continental Meeting of the International Society of Paediatric Oncology (SIOP), 6–9 March 2019, Cairo, Egypt

Khalek, Elhamy Rifky Abdel; Afungchwi, Glenn Mbah; Beltagy, Mohamed El; Ndagire, Mariam; Zaki, Hoda M.; Israëls, Trijn; Molyneux, Elizabeth; Howard, Scott C.; Patte, Catherine; Schoeman, Judy; Ladas, Elena J.; Zaghloul, Mohamed S.; ElDeen, Yasser S; Ahmed, Soha; Kamal, Sherif; Bouffet, Éric; Pritchard‐Jones, Kathy; Hessissen, Laïla

doi:10.3332/ecancer.2019.932

Cited by 7 publications

(13 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The lack of specialized equipment often resulted in delayed diagnosis, misdiagnosis, and suboptimal treatment options. 2 , 6 , 7 , 15 , 16 , 20 , 24 , 25 , 27 , 30 , 37 , 38 , 41 , 42 For example, Mezue et al 31 noted that while computed tomography and MRI are available in some healthcare facilities in Sub-Saharan Africa, their accessibility can be restricted in rural areas, leading to delayed diagnosis and treatment of intracranial tumors.…”

Section: Resultsmentioning

confidence: 99%

Neuro-oncology access in Sub-Saharan Africa: A literature review of challenges and opportunities

Yevudza,

Buckman,

Darko

et al. 2024

Neuro-Oncology Advances

View full text Add to dashboard Cite

Background Ensuring equitable access to treatments and therapies in the constantly evolving field of neuro-oncology is an imperative global health issue. With its unique demographic, cultural, socioeconomic, and infrastructure characteristics, Sub-Saharan Africa faces distinct challenges. This literature review highlights specific barriers to neuro-oncology care in the region and explores potential opportunities for enhancing access. Methods Predetermined keyword searches were employed to screen titles and abstracts using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses framework. Inclusion criteria were studies published between January 1, 2003, and June 20, 2023, specifically addressing the capacity and challenges of neuro-oncology in the Sub-Saharan African region. The data sources queried were PubMed and Google Scholar. Systematic reviews and meta-analyses were deliberately excluded. All authors conducted independent screening and structured data extraction meticulously. Results Our paper identified multiple challenges that impede access to quality treatment for brain tumors. These include constrained resources, insufficient training of healthcare professionals, certain cultural beliefs, and a general lack of awareness about brain tumors, all contributing to delayed diagnosis and treatment. Furthermore, the lack of detailed data on the incidence and prevalence of primary central nervous system tumors impairs the accurate assessment of disease burden and precise identification of areas requiring improvement. However, we discovered that ongoing research, advocacy, enhanced training, mentorship, and collaborative efforts present valuable opportunities for substantial progress in neuro-oncology access. Conclusions While we provide a glimpse of the current state, we hope these results will help stimulate dialogue and catalyze initiatives to surmount highlighted obstacles and improve neuro-oncology outcomes across Sub-Saharan Africa.

show abstract

Section: Resultsmentioning

confidence: 99%

Neuro-oncology access in Sub-Saharan Africa: A literature review of challenges and opportunities

Yevudza,

Buckman,

Darko

et al. 2024

Neuro-Oncology Advances

View full text Add to dashboard Cite

show abstract

“…In efforts to maximise the effective role of CCHE/Egypt in extending the GICC activities of the CureALL framework to other African and Arab countries, CCHE initiated effective partnerships and collaborations with professional institutions and governmental bodies in the region. Some collaborative efforts in Africa include partnership with the Ministry of Health in Guinea for professional development and capacity building at CCHE/Egypt [ 41 ]; conducting twinning programs with major African hospitals and academic institutes to disseminate the knowledge and resources of CCHE through training healthcare professionals (oncologists, nurses and pharmacists) at CCHE/Egypt [ 42 ]; and organising the 3rd African Continental Meeting of SIOP which was held in March 2019, in Cairo/Egypt [ 43 ]. Other collaborative efforts with Arab countries in the EMR include CCHE being designated as one of the authorised training sites in the region by the Pediatric Oncology East and Mediterranean group to share CCHE knowledge and resource for capacity building in the EMR [ 44 ], and partnership with the Iraqi Cancer Board to train nurses at CCHE [ 41 ].…”

Section: Discussionmentioning

confidence: 99%

An overview of childhood cancer care and outcomes in Egypt: a narrative review

Soliman,

Bolous,

Heneghan

et al. 2024

ecancer Journal

View full text Add to dashboard Cite

Childhood cancer is an urgent priority in Egypt, owing to a large number of children with cancer, the great need and demand for paediatric oncology services, limited resources/funds and inferior survival outcomes. Therefore, an overview of the status of childhood cancer care in Egypt and an evidence-based approach towards optimal utilisation of resources/funds to improve this care are needed. This paper summarises key evidence about childhood cancer care and outcomes in Egypt. We conducted a narrative literature review using a structured search strategy of the MEDLINE database through the PubMed interface. All relevant evidence was summarised under five main sub-topics: (1) burden of childhood cancer in Egypt; (2) treatment approaches; (3) health outcomes; (4) costs and cost-effectiveness of treatment; and (5) barriers and facilitators to optimal childhood cancer care. We found high estimates of disease burden of childhood cancer in Egypt. Furthermore, childhood cancer treatment in Egypt is based on either implementing intensity-regulated protocols or adopting international protocols with or without adaptations to local contexts, leading to varying standards of care among the different treating centres. Limited data about the survival outcomes, costs and cost-effectiveness of treatment exist, although high-quality data from retrospective cohort studies were published from a large paediatric oncology centre (Children’s Cancer Hospital Egypt–57357). As Egypt joins the WHO Global Initiative for Childhood Cancers as a focus country, it is prepared to move towards streamlining national efforts to implement a national childhood cancer plan to advance care, improve health outcomes and optimise resource use. Through these efforts, Egypt could become a beacon of hope and a role model to other low- and middle-income countries seeking to improve their childhood cancer care.

show abstract

“… 64 Other sources of scholarships include foundations, Ministries of Health and pharmaceutical companies. 66 74 …”

Section: Discussionmentioning

confidence: 99%

Conference equity in global health: a systematic review of factors impacting LMIC representation at global health conferences

et al. 2021

View full text Add to dashboard Cite

IntroductionGlobal health conferences are important platforms for knowledge exchange, decision-making and personal and professional growth for attendees. Neocolonial patterns in global health at large and recent opinion reports indicate that stakeholders from low- and middle-income countries (LMICs) may be under-represented at such conferences. This study aims to describe the factors that impact LMIC representation at global health conferences.MethodsA systematic review of articles reporting factors determining global health conference attendance was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Articles presenting conference demographics and data on the barriers and/or facilitators to attendance were included. Articles were screened at title and abstract level by four independent reviewers. Eligible articles were read in full text, analysed and evaluated with a risk of bias assessment.ResultsAmong 8765 articles screened, 46 articles met inclusion criteria. Thematic analysis yielded two themes: ‘barriers to conference attendance’ and ‘facilitators to conference attendance’. In total, 112 conferences with 254 601 attendees were described, of which 4% of the conferences were hosted in low-income countries. Of the 98 302 conference attendees, for whom affiliation was disclosed, 38 167 (39%) were from LMICs.Conclusion‘Conference inequity’ is common in global health, with LMIC attendees under-represented at global health conferences. LMIC attendance is limited by systemic barriers including high travel costs, visa restrictions and lower acceptance rates for research presentations. This may be mitigated by relocating conferences to visa-friendly countries, providing travel scholarships and developing mentorship programmes to enable LMIC researchers to participate in global conferences.

show abstract

Highlights from the 13th African Continental Meeting of the International Society of Paediatric Oncology (SIOP), 6–9 March 2019, Cairo, Egypt

Cited by 7 publications

References 19 publications

Neuro-oncology access in Sub-Saharan Africa: A literature review of challenges and opportunities

Neuro-oncology access in Sub-Saharan Africa: A literature review of challenges and opportunities

An overview of childhood cancer care and outcomes in Egypt: a narrative review

Conference equity in global health: a systematic review of factors impacting LMIC representation at global health conferences

Contact Info

Product

Resources

About